{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:49:25Z","timestamp":1791748165479,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.suronc.2026.102463","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:50:51Z","timestamp":1780415451000},"page":"102463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular subtypes and lymph-node metastasis in endometrial cancer: An updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3968-6618","authenticated-orcid":false,"given":"Rafael Alvim","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8855-0246","authenticated-orcid":false,"given":"Gabriel","family":"Barcellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6999-6019","authenticated-orcid":false,"given":"Milena","family":"Tumelero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4123-2413","authenticated-orcid":false,"given":"Antonino","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7564-3936","authenticated-orcid":false,"given":"Bianca","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7440-839X","authenticated-orcid":false,"given":"Gabriel","family":"Valagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-4476","authenticated-orcid":false,"given":"Nicolas","family":"Peruzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-525X","authenticated-orcid":false,"given":"Gabriel","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.suronc.2026.102463_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.suronc.2026.102463_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5114\/pm.2016.61186","article-title":"An update of the classical Bokhman's dualistic model of endometrial cancer","volume":"2","author":"Wilczy\u0144ski","year":"2016","journal-title":"Menopausal Rev."},{"issue":"10","key":"10.1016\/j.suronc.2026.102463_bib3","first-page":"1145","article-title":"WHO classification of female genital tumors","volume":"81","author":"H\u00f6hn","year":"2020","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"7447","key":"10.1016\/j.suronc.2026.102463_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.suronc.2026.102463_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2019.08.019","article-title":"TCGA molecular groups of endometrial cancer: pooled data about prognosis","volume":"155","author":"Raffone","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2026.102463_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"9","key":"10.1016\/j.suronc.2026.102463_bib7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2026.102463_bib8","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1007\/s12094-024-03401-y","article-title":"Molecular profile in endometrial carcinoma: can we predict the lymph node status? A systematic review and meta-analysis","volume":"26","author":"Luzarraga Aznar","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.suronc.2026.102463_bib9","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ (Online)"},{"issue":"2","key":"10.1016\/j.suronc.2026.102463_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.suronc.2026.102463_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics\u2010based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.suronc.2026.102463_bib12","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/1078-0432.CCR-15-2233","article-title":"Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis","volume":"22","author":"McConechy","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.suronc.2026.102463_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214318","article-title":"Phenotype of POLE-mutated endometrial cancer","volume":"14","author":"Imboden","year":"2019","journal-title":"PLoS One"},{"issue":"29","key":"10.1016\/j.suronc.2026.102463_bib14","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102463_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2020.01.019","article-title":"Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D","volume":"157","author":"Timmerman","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102463_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/diagnostics12010033","article-title":"Classification systems of endometrial cancer: a comparative study about old and new","volume":"12","author":"Coada","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.suronc.2026.102463_bib17","series-title":"E-Posters","first-page":"A81.3","article-title":"EPV130\/#537 endometrial cancer (EC): lymphovascular space invasion (LVSI) and lymph node metastasis (LNM) according to molecular subgroups","author":"Del Pezzo","year":"2021"},{"issue":"11","key":"10.1016\/j.suronc.2026.102463_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242733","article-title":"Clinical factors as prognostic variables among molecular subgroups of endometrial cancer","volume":"15","author":"Kolehmainen","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.suronc.2026.102463_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2022.01.007","article-title":"Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment","volume":"164","author":"Leon-Castillo","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2026.102463_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2022.01.025","article-title":"Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102463_bib21","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2022.33.e38","article-title":"Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study","volume":"33","author":"Yu","year":"2022","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102463_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5603\/GP.a2021.0177","article-title":"Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods","volume":"94","author":"Bayramoglu","year":"2023","journal-title":"Ginekol. Pol."},{"issue":"10","key":"10.1016\/j.suronc.2026.102463_bib23","first-page":"733","article-title":"[Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types]","volume":"58","author":"Li","year":"2023","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"9","key":"10.1016\/j.suronc.2026.102463_bib24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/ijgc-2024-005711","article-title":"SENECA study: staging endometrial cancer based on molecular classification","volume":"34","author":"Chacon","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.suronc.2026.102463_bib25","doi-asserted-by":"crossref","first-page":"S376","DOI":"10.1016\/j.ygyno.2024.07.559","article-title":"Molecular subtypes of endometrioid endometrial cancer predict rates of lymph node and ovarian metastasis at the time of surgical staging","volume":"190","author":"St Laurent","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.suronc.2026.102463_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2024.12.014","article-title":"Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups","volume":"193","author":"Siegenthaler","year":"2025","journal-title":"Gynecol. Oncol."},{"issue":"15","key":"10.1016\/j.suronc.2026.102463_bib27","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/cancers17152483","article-title":"Clinicopathological features and risk stratification of multiple-classifier endometrial cancers: a multicenter study from Poland","volume":"17","author":"Szatkowski","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.suronc.2026.102463_bib28","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2025.36.e112","article-title":"Modifying surgical extents in patients with preoperatively presumed early-stage endometrial cancer based on ProMisE classification: a retrospective, single-center study","volume":"36","author":"Lee","year":"2025","journal-title":"J. Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.suronc.2026.102463_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/jog.70065","article-title":"The relationship between lymph node metastasis and immunohistochemical molecular subtypes in endometrial cancer: a cohort study of 339 patients","volume":"51","author":"\u00d6nc\u00fc","year":"2025","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.suronc.2026.102463_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2022.12.010","article-title":"Can mismatch repair status be added to sentinel lymph node mapping algorithm in endometrioid endometrial cancer?","volume":"169","author":"Diniz","year":"2023","journal-title":"Gynecol. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426001143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426001143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:36:15Z","timestamp":1791747375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740426001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S0960740426001143"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102463","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular subtypes and lymph-node metastasis in endometrial cancer: An updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102463"}}